Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(18 sites)
United States
Research Site, Duarte, California Research Site, Los Angeles, California Research Site, Newport Beach, California Research Site, Jacksonville, Florida Research Site, Chicago, Illinois Research Site, Westwood, Kansas Research Site, Boston, Massachusetts Research Site, St Louis, Missouri Research Site, New York, New York Research Site, New York, New York Research Site, Philadelphia, Pennsylvania Research Site, Pittsburgh, Pennsylvania Research Site, Nashville, Tennessee Research Site, Dallas, Texas Research Site, Galveston, Texas Research Site, Houston, Texas Research Site, Aberdeen, Washington Research Site, Milwaukee, Wisconsin